(Q51694929)

9 April 2018

title

Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity. (English)

1 reference

9 April 2018

main subject

chronic liver disease

0 references

author

Emmanuel Tsochatzis

1

1 reference

9 April 2018

George Papatheodoridis

2

1 reference

9 April 2018

author name string

Emilia Hadziyannis

3

1 reference

9 April 2018

Anastasia Georgiou

4

1 reference

9 April 2018

Georgia Kafiri

5

1 reference

9 April 2018

Dina G Tiniakos

6

1 reference

9 April 2018

Emanuel K Manesis

7

1 reference

9 April 2018

Athanasios J Archimandritis

8

1 reference

9 April 2018

publication date

1 January 2008

1 reference

9 April 2018

Scandinavian Journal of Gastroenterology

published in

1 reference

9 April 2018

volume

43

1 reference

9 April 2018

issue

9

1 reference

9 April 2018

page(s)

1128-1136

1 reference

9 April 2018

The role of leptin in human obesity and disease: a review of current evidence

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

The evolving role of leptin and adiponectin in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

Insulin resistance: a metabolic pathway to chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

Adiponectin and its receptors in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

Serum adiponectin in chronic hepatitis C and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

High molecular weight adiponectin correlates with insulin sensitivity in patients with hepatitis C genotype 3, but not genotype 1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

Serum adiponectin concentration in patients with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802085387

10.1080/00365520802085387

21 January 2018

Identifiers

DOI

1 reference

9 April 2018

PubMed ID

18609175

1 reference

9 April 2018